Learn about PCSK9 inhibitors, the injectable cholesterol medications for high-risk patients. Explore how monoclonal antibodies and siRNA therapies lower LDL-C by 50-60%.
Learn about PCSK9 inhibitors, the injectable cholesterol medications for high-risk patients. Explore how monoclonal antibodies and siRNA therapies lower LDL-C by 50-60%.